Structural basis of bacterial defense against g-type lysozyme-based innate immunity
Gram-negative bacteria can produce specific proteinaceous inhibitors to defend themselves against the lytic action of host lysozymes. So far, four different lysozyme inhibitor families have been identified. Here, we report the crystal structure of the Escherichia coli periplasmic lysozyme inhibitor...
Published in: | Cellular and Molecular Life Sciences |
---|---|
Main Authors: | , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Birkhäuser Verlag
2013
|
Subjects: | |
Online Access: | https://lirias.kuleuven.be/handle/123456789/362011 https://doi.org/10.1007/s00018-012-1184-1 https://pubmed.ncbi.nlm.nih.gov/23086131 |
_version_ | 1828687167411453952 |
---|---|
author | Leysen, Seppe Vanderkelen, Lise Weeks, Stephen Michiels, Chris Strelkov, Sergei |
author_facet | Leysen, Seppe Vanderkelen, Lise Weeks, Stephen Michiels, Chris Strelkov, Sergei |
author_sort | Leysen, Seppe |
collection | KU Leuven: Lirias |
container_issue | 6 |
container_start_page | 1113 |
container_title | Cellular and Molecular Life Sciences |
container_volume | 70 |
description | Gram-negative bacteria can produce specific proteinaceous inhibitors to defend themselves against the lytic action of host lysozymes. So far, four different lysozyme inhibitor families have been identified. Here, we report the crystal structure of the Escherichia coli periplasmic lysozyme inhibitor of g-type lysozyme (PliG-Ec) in complex with Atlantic salmon g-type lysozyme (SalG) at a resolution of 0.95 Å, which is exceptionally high for a complex of two proteins. The structure reveals for the first time the mechanism of g-type lysozyme inhibition by the PliG family. The latter contains two specific conserved regions that are essential for its inhibitory activity. The inhibitory complex formation is based on a double 'key-lock' mechanism. The first key-lock element is formed by the insertion of two conserved PliG regions into the active site of the lysozyme. The second element is defined by a distinct pocket of PliG accommodating a lysozyme loop. Computational analysis indicates that this pocket represents a suitable site for small molecule binding, which opens an avenue for the development of novel antibacterial agents that suppress the inhibitory activity of PliG. sponsorship: Access to the synchrotron beamlines PROX-IMA1 at Soleil and X33 at the Deutsches Elektronen-Synchrotron is gratefully acknowledged, with a special 'thank you' to Dr. Andrew Thompson for help with ultrahigh-resolution data collection. We also thank Dr. Pavel Afonine for advice on crystallographic refinement. S. Leysen holds a doctoral grant from the K.U. Leuven. L. Vanderkelen holds a doctoral fellowship from the Flemish Institute for the Promotion of Scientific Technological Research (IWT). This work was further financially supported by a Research Grant (G.0363.08) from the Research Foundation-Flanders (F.W.O.-Vlaanderen) and from the KU Leuven Research Fund (research project METH/07/03). (K.U. Leuven, Flemish Institute for the Promotion of Scientific Technological Research (IWT), Research Foundation-Flanders ... |
format | Article in Journal/Newspaper |
genre | Atlantic salmon Salmo salar |
genre_facet | Atlantic salmon Salmo salar |
id | ftid14132:oai:lirias2repo.kuleuven.be:123456789/362011 |
institution | Open Polar |
language | English |
op_collection_id | ftid14132 |
op_container_end_page | 1122 |
op_doi | https://doi.org/10.1007/s00018-012-1184-1 |
op_relation | https://lirias.kuleuven.be/handle/123456789/362011 https://pubmed.ncbi.nlm.nih.gov/23086131 |
op_rights | info:eu-repo/semantics/restrictedAccess intranet |
op_source | ISSN:1420-682X ISSN:1420-9071 Cellular and Molecular Life Sciences, vol. 70 (6), (1113-1122) |
publishDate | 2013 |
publisher | Birkhäuser Verlag |
record_format | openpolar |
spelling | ftid14132:oai:lirias2repo.kuleuven.be:123456789/362011 2025-04-06T14:48:06+00:00 Structural basis of bacterial defense against g-type lysozyme-based innate immunity Leysen, Seppe Vanderkelen, Lise Weeks, Stephen Michiels, Chris Strelkov, Sergei 2013-03 https://lirias.kuleuven.be/handle/123456789/362011 https://doi.org/10.1007/s00018-012-1184-1 https://pubmed.ncbi.nlm.nih.gov/23086131 eng eng Birkhäuser Verlag https://lirias.kuleuven.be/handle/123456789/362011 https://pubmed.ncbi.nlm.nih.gov/23086131 info:eu-repo/semantics/restrictedAccess intranet ISSN:1420-682X ISSN:1420-9071 Cellular and Molecular Life Sciences, vol. 70 (6), (1113-1122) Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Cell Biology Lysozyme inhibitor PliG Lysozyme Innate immunity Inhibitory complex Crystal structure GOOSE-TYPE LYSOZYMES ESCHERICHIA-COLI INHIBITOR SCATTERING CHITINASE PROTEINS COMPLEX SYSTEM HEALTH MODEL Animals Crystallography Escherichia coli Escherichia coli Proteins Immunity Innate Models Molecular Muramidase Protein Conformation Salmo salar 0601 Biochemistry and Cell Biology 0606 Physiology 1103 Clinical Sciences 3101 Biochemistry and cell biology 3205 Medical biochemistry and metabolomics 3211 Oncology and carcinogenesis Journal article info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion 2013 ftid14132 https://doi.org/10.1007/s00018-012-1184-1 2025-03-13T09:55:15Z Gram-negative bacteria can produce specific proteinaceous inhibitors to defend themselves against the lytic action of host lysozymes. So far, four different lysozyme inhibitor families have been identified. Here, we report the crystal structure of the Escherichia coli periplasmic lysozyme inhibitor of g-type lysozyme (PliG-Ec) in complex with Atlantic salmon g-type lysozyme (SalG) at a resolution of 0.95 Å, which is exceptionally high for a complex of two proteins. The structure reveals for the first time the mechanism of g-type lysozyme inhibition by the PliG family. The latter contains two specific conserved regions that are essential for its inhibitory activity. The inhibitory complex formation is based on a double 'key-lock' mechanism. The first key-lock element is formed by the insertion of two conserved PliG regions into the active site of the lysozyme. The second element is defined by a distinct pocket of PliG accommodating a lysozyme loop. Computational analysis indicates that this pocket represents a suitable site for small molecule binding, which opens an avenue for the development of novel antibacterial agents that suppress the inhibitory activity of PliG. sponsorship: Access to the synchrotron beamlines PROX-IMA1 at Soleil and X33 at the Deutsches Elektronen-Synchrotron is gratefully acknowledged, with a special 'thank you' to Dr. Andrew Thompson for help with ultrahigh-resolution data collection. We also thank Dr. Pavel Afonine for advice on crystallographic refinement. S. Leysen holds a doctoral grant from the K.U. Leuven. L. Vanderkelen holds a doctoral fellowship from the Flemish Institute for the Promotion of Scientific Technological Research (IWT). This work was further financially supported by a Research Grant (G.0363.08) from the Research Foundation-Flanders (F.W.O.-Vlaanderen) and from the KU Leuven Research Fund (research project METH/07/03). (K.U. Leuven, Flemish Institute for the Promotion of Scientific Technological Research (IWT), Research Foundation-Flanders ... Article in Journal/Newspaper Atlantic salmon Salmo salar KU Leuven: Lirias Cellular and Molecular Life Sciences 70 6 1113 1122 |
spellingShingle | Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Cell Biology Lysozyme inhibitor PliG Lysozyme Innate immunity Inhibitory complex Crystal structure GOOSE-TYPE LYSOZYMES ESCHERICHIA-COLI INHIBITOR SCATTERING CHITINASE PROTEINS COMPLEX SYSTEM HEALTH MODEL Animals Crystallography Escherichia coli Escherichia coli Proteins Immunity Innate Models Molecular Muramidase Protein Conformation Salmo salar 0601 Biochemistry and Cell Biology 0606 Physiology 1103 Clinical Sciences 3101 Biochemistry and cell biology 3205 Medical biochemistry and metabolomics 3211 Oncology and carcinogenesis Leysen, Seppe Vanderkelen, Lise Weeks, Stephen Michiels, Chris Strelkov, Sergei Structural basis of bacterial defense against g-type lysozyme-based innate immunity |
title | Structural basis of bacterial defense against g-type lysozyme-based innate immunity |
title_full | Structural basis of bacterial defense against g-type lysozyme-based innate immunity |
title_fullStr | Structural basis of bacterial defense against g-type lysozyme-based innate immunity |
title_full_unstemmed | Structural basis of bacterial defense against g-type lysozyme-based innate immunity |
title_short | Structural basis of bacterial defense against g-type lysozyme-based innate immunity |
title_sort | structural basis of bacterial defense against g-type lysozyme-based innate immunity |
topic | Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Cell Biology Lysozyme inhibitor PliG Lysozyme Innate immunity Inhibitory complex Crystal structure GOOSE-TYPE LYSOZYMES ESCHERICHIA-COLI INHIBITOR SCATTERING CHITINASE PROTEINS COMPLEX SYSTEM HEALTH MODEL Animals Crystallography Escherichia coli Escherichia coli Proteins Immunity Innate Models Molecular Muramidase Protein Conformation Salmo salar 0601 Biochemistry and Cell Biology 0606 Physiology 1103 Clinical Sciences 3101 Biochemistry and cell biology 3205 Medical biochemistry and metabolomics 3211 Oncology and carcinogenesis |
topic_facet | Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Cell Biology Lysozyme inhibitor PliG Lysozyme Innate immunity Inhibitory complex Crystal structure GOOSE-TYPE LYSOZYMES ESCHERICHIA-COLI INHIBITOR SCATTERING CHITINASE PROTEINS COMPLEX SYSTEM HEALTH MODEL Animals Crystallography Escherichia coli Escherichia coli Proteins Immunity Innate Models Molecular Muramidase Protein Conformation Salmo salar 0601 Biochemistry and Cell Biology 0606 Physiology 1103 Clinical Sciences 3101 Biochemistry and cell biology 3205 Medical biochemistry and metabolomics 3211 Oncology and carcinogenesis |
url | https://lirias.kuleuven.be/handle/123456789/362011 https://doi.org/10.1007/s00018-012-1184-1 https://pubmed.ncbi.nlm.nih.gov/23086131 |